October 2024 Archive
GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies
Monday, October 14, 2024
PALO ALTO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- GEn1E Lifesciences, a clinical-stage Phase 2 company, and a leading innovator in precision therapies for inflammatory and rare diseases, with a strong partnership with the University of Maryland, Baltimore (UMB), today announced the publication... read more
UM Ventures, Baltimore Newsletter
Thursday, October 3, 2024
Have an invention?Disclose it to the UM Ventures, Baltimore team. Featured Article CoapTech Receives UM Ventures, Baltimore Follow-on Investment UM Ventures, Baltimore participated in CoapTech's Series B2 Preferred Stock Financing round, marking the 19th... read more
UMB Patent Awards | April - June 2024
Thursday, October 3, 2024
Delivery Devices for Forming A Distal Anchor For Mitral Valve RepairUnited States Continuation issued April 2, 2024 UMB Inventor: James Gammie, MD (formerly UMSOM) Noninvasive Quantitation of Full Versus Empty Capsids Using Water Proton NMRUnited States Continuation in Part issued April 2, 2024... read more
President’s Entrepreneurial Fellowship Alumni Feature | Varun Ayyaswami, MD '20
Thursday, October 3, 2024
Through the PEF program, Dr. Ayyaswami was able to explore his passion for applying innovative research to real-world patient care. As a fourth-year, primary care track medical student, Varun Ayyaswami, MD ‘20, learned about the President’s Entrepreneurial... read more
Featured Partner: Vivpro AI
Thursday, October 3, 2024
VivproAI, a rapidly growing University of Maryland School of Pharmacy (UMSOP) spinout, is developing a revolutionary biointelligence software platform for medical products. The platform, R&D Intelligence Assistant (RIA), mines, curates, and integrates complex data assets and information, making... read more
Featured Inventor: Tao Lowe, PhD
Thursday, October 3, 2024
Dr. Lowe is a renowned expert in biomaterials for translational research and technology development. Tao Lowe, PhD, is an internationally renowned expert in biomaterials for translational research and technology development, especially in the areas of drug and gene... read more
CoapTech Receives UM Ventures, Baltimore Follow-on Investment
Thursday, October 3, 2024
University of Maryland Ventures, Baltimore (UMVB) recently joined CoapTech’s Series B2 Preferred Stock Financing round, investing $125,000 in the University of Maryland, Baltimore (UMB) medical device startup. This represents the 19th investment made through the UMVB equity investment program, with... read more
UM Ventures, Baltimore and Blackbird Labs Co-invest to Develop UMB Therapeutic Technology
Wednesday, October 2, 2024
Baltimore-based, next-generation life sciences accelerator, Blackbird Labs, and University of Maryland Ventures, Baltimore, University of Maryland, Baltimore’s (UMB) technology transfer and commercialization division, are excited to announce that they have entered into an overarching co-investment... read more